Kexing Biopharm Logo

Kexing Biopharm

Develops and produces recombinant protein drugs and micro-ecological preparations.

688136 | Shanghai Stock Exchange

Overview

Corporate Details

ISIN(s):
CNE100006ZG6
LEI:
529900Z34Q1M9A907771
Country:
China
Address:
N/A

Description

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-01 21:05
Kexing Biopharm prasentiert globale Strategie und Kooperationsmoglichkeiten auf…
German 6.4 KB

Automate Your Workflow. Get a real-time feed of all Kexing Biopharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kexing Biopharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kexing Biopharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GlaxoSmithKline PLC Logo
A global biopharma company developing medicines and vaccines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops incrementally modified drugs using advanced drug delivery technologies.
South Korea
204840
GNI  Group Ltd. Logo
Multinational biopharma firm developing drugs, TCMs, and medical devices.
Japan
2160
Goodwill Pharma Plc Logo
Develops, manufactures, and distributes medicines, supplements, and medical devices.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing an inhaled therapy for pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Late-stage biopharma developing drugs for rare and orphan neurological conditions.
United States of America
GRCE
Green Cross Corporation Logo
Develops protein therapeutics, vaccines, diagnostics, and consumer health products.
South Korea
006280
A holding company in biopharma, diagnostics, consumer, and digital healthcare.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops nutritional injections, health supplements, and cosmetics.
South Korea
234690
Greenwich LifeSciences, Inc. Logo
A clinical-stage biopharma developing immunotherapies to prevent cancer recurrence.
United States of America
GLSI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.